These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2766740)

  • 21. Oral treatment of peritonitis complicating continuous ambulatory peritoneal dialysis.
    Searle M; Raman GV
    Clin Nephrol; 1985 May; 23(5):241-4. PubMed ID: 4006333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between peritoneal mesothelial cell cytology and peritoneal histopathology with respect to prognosis in patients on continuous ambulatory peritoneal dialysis.
    Izumotani T; Ishimura E; Yamamoto T; Otoshi T; Okuno S; Inaba M; Kim M; Nishizawa Y
    Nephron; 2001 Sep; 89(1):43-9. PubMed ID: 11528231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Making long-term peritoneal dialysis possible.
    Dombros NV; Digenis GE; Oreopoulos DG
    Int J Artif Organs; 1997 Mar; 20(3):129-33. PubMed ID: 9151146
    [No Abstract]   [Full Text] [Related]  

  • 24. CAPD is a second-class treatment.
    Shaldon S; Koch KM; Quellhorst E; Lonnemann G; Dinarello CA
    Contrib Nephrol; 1985; 44():163-72. PubMed ID: 3872770
    [No Abstract]   [Full Text] [Related]  

  • 25. Response of CAPD patients with a high incidence of peritonitis to intraperitoneal immunoglobulin therapy.
    Carozzi S; Nasini MG; Kunkl A; Cantarella S; Lamperi S
    ASAIO Trans; 1988; 34(3):635-9. PubMed ID: 3264176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Posttransplant peritonitis in a CAPD patient.
    Cramer SO; Adams MB; Kauffman HM
    Transplantation; 1983 Sep; 36(3):340-1. PubMed ID: 6351375
    [No Abstract]   [Full Text] [Related]  

  • 27. Double bag or Y-set versus standard transfer systems for continuous ambulatory peritoneal dialysis in end-stage renal disease.
    Daly C; Campbell M; Cody J; Grant A; Donaldson C; Vale L; Lawrence P; MacLeod A; Wallace S; Khan I
    Cochrane Database Syst Rev; 2001; (2):CD003078. PubMed ID: 11406068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunologic patterns in CAPD patients with peritonitis.
    Lamperi S; Carozzi S
    Clin Nephrol; 1988; 30 Suppl 1():S41-4. PubMed ID: 3052960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of intraperitoneal administration of sandoglobulin on peritoneal fluid IgG level in patients treated by standard peritoneal dialysis (SPD)].
    Wańkowicz Z; Panasiuk-Jarzyło E; Pietrzak B; Szczylik C; Raczka A; Kłos M
    Pol Arch Med Wewn; 1992 Jan; 87(1):14-20. PubMed ID: 1641361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple-dose-kinetics of ofloxacin after intraperitoneal application in CAPD patients.
    Kampf D; Borner K; Hain H; Conrad W
    Perit Dial Int; 1991; 11(4):317-21. PubMed ID: 1751596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific opsonic activity for staphylococci in peritoneal dialysis effluent during continuous ambulatory peritoneal dialysis.
    Nielsen H; Espersen F; Kharazmi A; Antonsen S; Ejlersen E; Joffe P; Pedersen FB
    Am J Kidney Dis; 1992 Oct; 20(4):372-5. PubMed ID: 1415206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experience regarding reduction of peritonitis rates in continuous ambulatory peritoneal dialysis.
    Faller B; Genestier S; Bodenreider O; Brignon P; Boess G
    Perit Dial Int; 1993; 13 Suppl 2():S319-21. PubMed ID: 8399598
    [No Abstract]   [Full Text] [Related]  

  • 33. Continuous ambulatory peritoneal dialysis- a new dimension in the treatment of end-stage renal disease.
    Shohat J; Boner G; Rosenfeld J; Waller A; Iaina A; Eliahou HE
    Isr J Med Sci; 1982 Oct; 18(10):1014-8. PubMed ID: 7174268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory peritoneal dialysis in a Mexican PD center.
    Sanchez AR; Madonia C; Rascon-Pacheco RA
    Kidney Int Suppl; 2008 Apr; (108):S76-80. PubMed ID: 18379553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peritonitis prevention in continuous ambulatory peritoneal dialysis.
    Luzar MA
    Nephrologie; 1992; 13(4):171-7. PubMed ID: 1407258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of 300 mg/d Intraperitoneal Daptomycin: New Insight from the DaptoDP Study.
    Saint Paul LP; Ficheux M; Debruyne D; Loilier M; Bouvier N; Morello R; Verdon R; Le Blanc E; Cattoir V; Lobbedez T
    Perit Dial Int; 2018; 38(6):463-466. PubMed ID: 30413641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recovery of gastrointestinal function after renal transplantation in a patient with sclerosing peritonitis secondary to continuous ambulatory peritoneal dialysis.
    Hawley CM; Wall DR; Johnson DW; Campbell SB; Griffin AD; Rigby RJ; Petrie JJ
    Am J Kidney Dis; 1995 Oct; 26(4):658-61. PubMed ID: 7573023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Staph aureus peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Kim D; Tapson J; Wu G; Khanna R; Vas SI; Oreopoulos DG
    Trans Am Soc Artif Intern Organs; 1984; 30():494-7. PubMed ID: 6533929
    [No Abstract]   [Full Text] [Related]  

  • 39. Relapsing CAPD peritonitis with rapid peritoneal sclerosis due to Haemophilus influenzae.
    Chew CG; Clarkson AR; Faull RJ
    Nephrol Dial Transplant; 1997 Apr; 12(4):821-2. PubMed ID: 9141024
    [No Abstract]   [Full Text] [Related]  

  • 40. The Glasgow CAPD system.
    Henderson I; Juhasz L; McArdle C; Fleeting D
    Int J Artif Organs; 1982 Jan; 5(1):25-6. PubMed ID: 7068262
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.